Lexpert Magazine

Nov/Dec 2017

Lexpert magazine features articles and columns on developments in legal practice management, deals and lawsuits of interest in Canada, the law and business issues of interest to legal professionals and businesses that purchase legal services.

Issue link: https://digital.carswellmedia.com/i/894157

Contents of this Issue

Navigation

Page 63 of 91

64 LEXPERT MAGAZINE | NOVEMBER/DECEMBER 2017 FEATURE SOME 18 MONTHS aer amendments by the Canadian Securities Ad- ministrators to the takeover-bid rules, which came into effect in May 2016, predic- tions that the changes would alter processes and strategies in the hostile M&A mar- ket appear to have been borne out — at least in part. e key changes mandated a 105-day minimum deposit period, a 50-per-cent minimum tender requirement, and a compulsory 10-day extension of bids where a bidder had received tenders of more than 50 per cent of outstanding securities. e extended 105-day minimum deposit period, a significant uptick from the original 35 days, has given targets 70 additional days to find a white knight bidder. is has reduced the relevance and efficacy of shareholder rights plans (also known as "poison pills"), the traditional defence of choice in response to unsolicited bids. e new "just say slow" minimum bid period also gives other interested bidders a longer period to intervene, creating uncertainty for initial bidders, especially hostile ones — an uncertainty that could give boards more negotiating leverage. "Poison pills are redundant now, because they amount to a tactic used to buy time, some- thing the regulators have now provided," says John Emanoilidis, a partner in the Toronto office of Torys LLP. While the new regime contemplates exceptions to the 105-day regime, M&A lawyers predicted that they would be hard to come by, granted only when the expiry of the new bid period approached and then only in extraordinary circumstances. "If someone tried to issue a poison pill on day 104, it might buy them a few days but it would soon be struck down," says Chris Sunstrum of Goodmans LLP in Toronto. Defensive WITH AMENDMENTS RENDERING THE 'POISON PILL' EFFECTIVELY INERT, PRIVATE PLACEMENTS HAVE BECOME THE DE FACTO M&A DEFENSIVE TACTIC. BUT THERE ARE LIMITS TO THEIR USEFULNESS BY JULIUS MELNITZER PHOTO: SHUTTERSTOCK Workaround

Articles in this issue

Links on this page

Archives of this issue

view archives of Lexpert Magazine - Nov/Dec 2017